Navigation

Breast cancer (early) - paclitaxel

Paclitaxel for the treatment of early breast cancer

Status: History
Expected date of issue: August 2006
Process: STA
Topic area:
 

NICE project team

Executive Lead: Andrea Sutcliffe
Technical Lead: Elisabeth George
Communications manager: Sarita Tamber
Project manager: Emily Marschke
Assessment Group / Evidence Review Group: Centre for Health Economics, University of York and the Regional Drug and Therapeutics Centre, Newcastle
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 09 January 2006
1st appraisal committee meeting: 05 April 2006
2nd appraisal committee meeting TBC
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)
Manufacturers / Sponsors
  • Bristol-Myers Squibb Pharmaceuticals Ltd (paclitaxel)
Patient / Carer Groups
  • Breakthrough Breast Cancer
  • Breast Cancer Care
  • Cancer BACUP
  • Cancer Voices
  • Long Term Medical Conditions Alliance
  • Macmillan Cancer Relief
  • National Cancer Alliance
  • Tenovus Cancer Information Centre
Professional Groups
  • Association of Cancer Physicians
  • Association of Surgeons of Great Britain & Ireland
  • British Association of Surgical Oncology
  • British Oncological Association
  • British Oncology Pharmacy Association (BOPA)
  • Cancer Research UK0
  • Community Practitioners' & Health Visitors Association
  • Medical Women's Federation
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians' Medical Oncology Joint Special Committee
  • Royal College of Radiologists
  • Royal College of Surgeons
Others
  • Department of Health
  • Eden Valley PCT
  • North Liverpool PCT
  • Welsh Assembly Government

 

General
  • British National Formulary
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Coordinating Centre for Health Technology Assessment
  • NHS Confederation
  • NHS Purchasing and Supplies Agency
  • NHS Quality Improvement Scotland
Comparator Manufacturers
  • Baxter Healthcare Ltd
  • Bayer plc
  • Genus Pharmaceuticals Ltd
  • Goldshield Pharmaceuticals Ltd
  • Mayne Pharma plc
  • Medac UK
  • Pfizer Ltd
  • Sanofi-Aventis
  • Teva UK Ltd
Evidence Review Groups
  • None
Associated Guideline Groups
  • National Collaborating Centre for Cancer
Associated Public Health Groups
  • none
Research Groups
  • Cochrane Collaboration - Cochrane Breast Cancer Group
  • Institute of Cancer Research
  • MRC Clinical Trials Unit
  • National Cancer Research Institute

 

Top


 

Project history

Date Summary
13 December 2005 Evidence review group added
30 January 2006 Consultees and commentators added
22 March 2006 Project team updated
20 April 2006 Project team, consultees and commentators and schedule updated
25 May 2006 Updated assessment group.
   
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.